Full-Time

Global HEOR Business Partner

Oncology

Posted on 12/2/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Cambridge, MA, USA + 1 more

More locations: Bridgewater Township, NJ, USA

Onsite presence required.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Strong strategic and analytical skills to translate clinical and economic information and messages into payer evidence strategies.
  • Strong customer focus
  • Ability to work well in a cross-functional team
  • Understanding of the disease environment and the evolution of the market access landscape and implications for the business
  • At least 7 years of experience in HEOR or market access in pharmaceutical industry, CRO or academic experience
  • Global experience is a must
  • Proven track record working successfully in a project/matrix-oriented environment
  • Strategic mindset and proven innovation/out of the box thinking in evidence generation/value documentation
  • Excellent communication skills and ability to understand and present complex information in digestible ways for internal (e.g. senior management) and external audiences
  • Strong team spirit, sense of transversality, multicultural awareness and ability to drive matrix teams
  • Understands reimbursement decisions to determine value drivers and how evidence is used in decision making and how it impacts various payers (e.g., providers, patients, health systems)
  • Knowledge of methods and principles of health economics, health technology assessment (HTA) reviews
  • Systematically reviewed available scientific evidence to identify clinical needs of the payer
  • Provided timely and strategic recommendations to clinical development programs aimed at ensuring differentiation for payer value demonstration
  • Translated Target Value Propositions and access strategies into evidence hypotheses, requirements and generation plans addressing payer/provider/health system unmet needs
  • Understands, creates and applies relevant methods (e.g., observational data, post hoc analysis of clinical trials, meta-analysis, indirect comparison, etc..) to demonstrate product value potential
  • Has created and applied state-of-the-art decision analyses in order to meet payer/provider methodological best practices
  • Understands the risks and opportunities deriving from generating Real World Evidence
  • Advanced degree (Doctoral or Masters level) in relevant field
  • Demonstrated understanding disease physiopathology, drug mechanism of action, clinical development principles, epidemiology, biostatistics, statistical programming, patient-reported outcome development, systemic literature reviews, network meta-analyses
  • English fluent required
Responsibilities
  • Deliver quality research projects, economic models, trial design recommendations and other activities in support of programs/products.
  • The incumbent interfaces with Clinical, Medical Affairs and business partners including Marketing, External Affairs and Market Access.
  • He/she is accountable for the planning, design, implementation and completion of innovative evidence based research programs that are consistent with program/product strategies.
  • The research programs developed will provide appropriate evidence and/or tools to be used for internal decision making and for external audiences at product launch and over product life cycle.
  • Develops strategies and provides new ideas and concepts on how to move the program, product or therapeutic franchise forward.
  • Manage the HEVA evidence generation strategy.
  • Execute approved HEVA studies and manage ongoing studies according to budget and timeline expectations.
  • Identify new HEVA evidence generation opportunities to maximize lifecycle management.
  • Assist countries in developing or adapting health economic models and other materials for reimbursement, payer objection handling and other purposes.
  • Develop and maintain effective relationships with key internal stakeholders including North American Medical Affairs, European Medical Affairs, Sanofi Emerging Market regional teams, and Established Products.
  • Sets strategic evidence generation priorities and direction for assigned responsibilities and is able to incorporate this into appropriate planning documents.
  • Takes a leadership role in the development of relationships and continued advocacy with external advisors in appropriate therapeutic areas.
  • Develops collaborative research relationships that provide data of value to decision makers.
  • Leverages interactions to identify strategies that will improve the impact of research and build advocates for data.
  • Interacts with senior level management providing high level strategies and long term vision of assigned work.
  • Implementation of evidence generation tactics consistent with HEVA strategic goals including designing, budgeting, contracting, tracking, reporting, and publication plans.
  • Provides input to clinical and medical teams regarding opportunities to execute HEVA strategies within their planned research activities by identifying the appropriate evidence to collect and report.
  • Serves as a resource to commercial organization in terms of pricing, positioning and reimbursement of products based on economic evaluations.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?